Keith Katkin, Director: Syndax Pharmaceuticals SNDX Buy · Filed 25/05/19

Trade details

Type: Insider buy
Amount: $91,100
Shares · price: 10,000 sh · $9.11 a share
Held after: 100,000 sh
Stock: Syndax Pharmaceuticals SNDX
Person: Keith KatkinDirector
Trade date: 25/05/19
Filed: 25/05/19
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 4 insiders
Holding change: +11.1%

Syndax Pharmaceuticals trades, last 26 weeks

What else happened in Syndax Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/04/19~25/06/18

Keith Katkin's recent trades

Keith KatkinDirector
Sell10b5-1 planEmergent BioSolutions
Sell10b5-1 plan
Emergent BioSolutions
EBS
$128.2K
15,481 sh
$128.2K
Filed 05/04
Traded 04/30
Keith KatkinDirector
Planned sale10b5-1 planEmergent BioSolutions
Planned sale10b5-1 plan
Emergent BioSolutions
EBS
$128.1K
15,481 sh
$128.1K
Filed 04/30
Traded 04/30
Keith KatkinDirector
Sell10b5-1 planEmergent BioSolutions
Sell10b5-1 plan
Emergent BioSolutions
EBS
$49.4K
7,844 sh
$49.4K
Filed 25/05/28
Traded 25/05/23
Keith KatkinDirector
Planned sale10b5-1 planEmergent BioSolutions
Planned sale10b5-1 plan
Emergent BioSolutions
EBS
$49.4K
7,844 sh
$49.4K
Filed 25/05/23
Traded 25/05/23